| P2093 | author name string | Tone Bjørge | |
| | Olav K Vintermyr | |
| | Robert Skar | |
| | Hans K Haugland | |
| | Bjørn O Maehle | |
| | Elisabeth B Budal | |
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| | Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis | Q28143403 |
| | Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 |
| | Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study | Q33834332 |
| | Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis | Q33883532 |
| | Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia | Q34299355 |
| | The cervical cancer epidemic that screening has prevented in the UK. | Q34334371 |
| | Findings to date from the ASCUS-LSIL Triage Study (ALTS). | Q35182060 |
| | Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme | Q35324720 |
| | Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice | Q35738881 |
| | Natural history of cervical neoplasia: consistent results obtained by an identification technique | Q36468124 |
| | Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. | Q36695105 |
| | Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections | Q36994715 |
| | Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up | Q37065936 |
| | Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 |
| | Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study | Q37137085 |
| | Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study | Q37281729 |
| | Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model | Q37450177 |
| | A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection | Q37892308 |
| | Natural history of cervical intraepithelial neoplasia: a critical review. | Q40891994 |
| | The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri | Q40982984 |
| | Structure and transcription of human papillomavirus sequences in cervical carcinoma cells | Q41914039 |
| | Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening | Q44876752 |
| | The health and economic effects of HPV DNA screening in The Netherlands | Q45496797 |
| | Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. | Q50712519 |
| | Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. | Q51724712 |
| | Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 |
| | Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 |
| | Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. | Q53398008 |
| | Human papillomavirus and cervical cancer | Q54023273 |
| | Overview of the European and North American studies on HPV testing in primary cervical cancer screening | Q57414808 |
| | A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion | Q58475803 |
| | Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial | Q73446985 |
| | The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study | Q74113678 |
| | A NEW PROCEDURE FOR STAINING VAGINAL SMEARS | Q81217832 |
| | Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 |
| | Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 |
| | HPV test shows low sensitivity of Pap screen in older women | Q84351247 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Norway | Q20 |
| P304 | page(s) | 182-189 | |
| P577 | publication date | 2013-12-17 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway | |
| P478 | volume | 3 | |